Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Published in Law and Health Weekly, August 25th, 2007
"Emisphere's product pipeline is growing increasingly robust," said Michael V. Novinski, President/Chief Executive Officer of Emisphere Technologies, Inc. "In addition to the 10 products we have in various stages of clinical development, we have an additional 11 pre-clinical projects in our pipeline, six with partners and five without established collaborations. We are seeking to move our patented technology into a broad array of disease states, including obesity, osteoporosis, infectious disease, diabetes, CNS, erectile dysfunction and fertility...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Aarp
Seniors Set to be Hit Hard by Illinois Budget - Americans United for Life
Kansas Abortionist Tiller's Claims Without Merit Americans United for Life Amicus Brief Says - Amyotrophic Lateral Sclerosis
New findings from Columbia University in the area of amyotrophic lateral sclerosis published - BG Medicine, Inc.
BG Medicine Files US Registration Statement with SEC in Support of Euronext Amsterdam IPO - Bioengineering
AutoImmune Inc. Reports 2007 Second Quarter Financial Results - Bioengineering
Point Therapeutics Reports Second Quarter 2007 Financial Results - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
